Penetration of Ceftazidime into Human Pancreas

Overview

Journal Infection

Date 1993 Jul 1

PMID 8225626

Citations 1

Authors

B Drewelow

K Koch

C Otto

A Franke

A K Riethling

Affiliations

Soon will be listed here.

Abstract

The use of antibiotics in patients with severe acute pancreatitis (stage II and III) is indicated since bacterial complications are the most common cause of death in these patients. In the present study the penetration of ceftazidime into pancreatic juice, into healthy and chronically inflamed pancreatic tissue as well as into necrotic regions in cases of severe acute pancreatitis was investigated. A peak concentration of 12.9 +/- 5.9 mg/l was found 60 min after intravenous administration of 35 mg/kg of the drug, which is 32% of the corresponding serum levels. Pancreatic tissue concentrations varied between 9 and 79% of the corresponding serum levels, depending on the stage of inflammation. After five days of antibiotic treatment with doses of 2 g t.i.d., concentrations between 1.8 and 6.9 mg/kg were detected even in pancreatic necroses. This suggests that sufficient antibacterial levels of ceftazidime were present in all pancreatic compartments analyzed following administration of common therapeutic dosages. Therefore, from a pharmacokinetic point of view, ceftazidime could be a potentially effective drug for the treatment of pancreatitis.

Citing Articles

Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Rains C, Bryson H, Peters D Drugs. 1995; 49(4):577-617.

PMID: 7789291 DOI: 10.2165/00003495-199549040-00008.

References

Roberts E, Williams R . Ampicillin concentrations in pancreatic fluid bile obtained at endoscopic retrograde cholangiopancreatography (ERCP). Scand J Gastroenterol. 1979; 14(6):669-72. DOI: 10.3109/00365527909181935. View

Klempa I, Baca I, Menzel J, Schuszdiarra V . [Effect of somatostatin on basal and stimulated exocrine pancreatic secretion after partial duodenopancreatectomy. A clinical experimental study]. Chirurg. 1991; 62(4):293-9. View

Wilkins T, West S . Therapy of anaerobic infections. Infection. 1983; 11 Suppl 2:S105-8. DOI: 10.1007/BF01645299. View

Meulemans A, Vicart P, Mohler J, Vulpillat M . Determination of antibiotic lipophilicity with a micromethod: application to brain permeability in man and rats. Chemotherapy. 1988; 34(2):90-5. DOI: 10.1159/000238553. View

Bittner R, Block S, Buchler M, Beger H . Pancreatic abscess and infected pancreatic necrosis. Different local septic complications in acute pancreatitis. Dig Dis Sci. 1987; 32(10):1082-7. DOI: 10.1007/BF01300192. View

Koch K, Drewelow B, LIEBE S, Reding R, Riethling A . [Pancreatic penetration of antibiotics]. Chirurg. 1991; 62(4):317-22. View

Burns G, Stein T, Kabnick L . Blood-pancreatic juice barrier to antibiotic excretion. Am J Surg. 1986; 151(2):205-8. DOI: 10.1016/0002-9610(86)90070-x. View

Brattstrom C, Tyden G, MALMBORG A, Lundgren G, Ost L, Groth C . Studies of the exocrine secretion of segmental pancreatic grafts with special reference to the diagnosis of rejection and to the penetration of drugs into the pancreatic juice. Transplant Proc. 1987; 19(1 Pt 3):2332-5. View

Brattstrom C, MALMBORG A, Tyden G . Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man. Surgery. 1988; 103(5):563-7. View

10.

Finch W, SAWYERS J, Schenker S . A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg. 1976; 183(6):667-71. PMC: 1344270. DOI: 10.1097/00000658-197606000-00008. View

11.

Beger H, Bittner R, Block S, Buchler M . Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986; 91(2):433-8. DOI: 10.1016/0016-5085(86)90579-2. View

12.

Bradley 3rd E . Management of infected pancreatic necrosis by open drainage. Ann Surg. 1987; 206(4):542-50. PMC: 1493219. DOI: 10.1097/00000658-198710000-00015. View

13.

CRAIG R, DORDAL E, Myles L . Letter: The use of ampicillin in acute pancreatitis. Ann Intern Med. 1975; 83(6):831-2. DOI: 10.7326/0003-4819-83-6-831. View

14.

Buchler M, Malfertheiner P, Friess H, Bittner R, Vanek E, Schlegel P . The penetration of antibiotics into human pancreas. Infection. 1989; 17(1):20-5. DOI: 10.1007/BF01643494. View

15.

Brown R, Kinnick M, Morin Jr J, Vasileff R, COUNTER F, Davidson E . Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins. J Med Chem. 1990; 33(8):2114-21. DOI: 10.1021/jm00170a011. View

16.

Lumsden A, Bradley 3rd E . Secondary pancreatic infections. Surg Gynecol Obstet. 1990; 170(5):459-67. View

17.

Frey C, Bradley 3rd E, Beger H . Progress in acute pancreatitis. Surg Gynecol Obstet. 1988; 167(4):282-6. View

18.

Benveniste G, Morris R . Penetration of cefotaxime into pancreatic juice. Lancet. 1985; 1(8428):588-9. DOI: 10.1016/s0140-6736(85)91252-8. View

19.

Neu H . Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med. 1985; 79(2A):2-13. DOI: 10.1016/0002-9343(85)90254-2. View

20.

Rethel R, Hoffmann U, Hoffmeister A, Seyfried J, Wagner L, Walker G . [Pancreatic metabolism of sulfamethoxazole and trimethoprim]. Med Welt. 1980; 31(26):991-4. View